Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/07/2012 | CN102770416A Metaxalone cocrystals |
11/07/2012 | CN102770415A Polycyclic compounds as lysophosphatidic acid receptor antagonists |
11/07/2012 | CN102770414A [5,6] heterocyclic compound |
11/07/2012 | CN102770413A 5-amino- 4-hydroxypentoyl amides |
11/07/2012 | CN102770412A (Methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses |
11/07/2012 | CN102770182A Substituted isoquinolinones and quinazolinones |
11/07/2012 | CN102770181A Novel antiviral compounds |
11/07/2012 | CN102770159A Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
11/07/2012 | CN102770143A Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture |
11/07/2012 | CN102770142A Diazoxide for use in the treatment of a central nervous system (CNS) autoimmune demyelinating disease |
11/07/2012 | CN102770141A Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
11/07/2012 | CN102770140A Method of threating cancer |
11/07/2012 | CN102770139A Sanglifehrin based compounds |
11/07/2012 | CN102770138A Nicotine-containing soft gelatin pastilles |
11/07/2012 | CN102770137A Tumour treatment agents and method |
11/07/2012 | CN102770136A Therapeutic agent (Y - 39983) for corneal endothelial dysfunction |
11/07/2012 | CN102770135A Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect |
11/07/2012 | CN102770134A Treatment of infectious diseases |
11/07/2012 | CN102770133A sGC stimulators or sGC activators alone and in combination with PDE5 inhibitors for the treatment of cystic fibrosis |
11/07/2012 | CN102770131A Novel antitumoral use of cabazitaxel |
11/07/2012 | CN102770130A Adhesive patch containing bisoprolol |
11/07/2012 | CN102770129A Methods and compositions for treating cance |
11/07/2012 | CN102770128A Method for preventing the crystallisation of pharmaceuticals in a polymer film |
11/07/2012 | CN102770127A Abuse-resistant formulations |
11/07/2012 | CN102770126A Apixaban formulations |
11/07/2012 | CN102770125A Calcipotriol monohydrate nanocrystals |
11/07/2012 | CN102770124A Formulation comprising 1 H - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
11/07/2012 | CN102770123A Highly permeating terbinafine formulation for treating onychomycosis |
11/07/2012 | CN102770121A Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue |
11/07/2012 | CN102770120A Compositions and methods for mild sedation, anxiolysis and analgesia in the procedural setting |
11/07/2012 | CN102770026A Combination |
11/07/2012 | CN102770024A Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
11/07/2012 | CN102766634A Single-stranded deoxyribonucleic acid (ssDNA) aptamer targeting human highly metastatic hepatoma carcinoma cell and application thereof |
11/07/2012 | CN102766632A Golgi apparatus membrane protein GP73 nucleic acid aptamer, as well as preparation method and application thereof |
11/07/2012 | CN102766262A Preparation method for difunctional nanoparticle carrier and preparation method for difunctional nanoparticle preparation |
11/07/2012 | CN102766258A Resveratrol hydrophilic conjugate, its preparation method and application |
11/07/2012 | CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof |
11/07/2012 | CN102766187A Ginsenoside Compound-K ester derivative and application thereof to preparation of medicament for prophylaxis and treatment of atherosclerosis |
11/07/2012 | CN102766186A Preparation method and application of ecdysone-rich plant standardized extract |
11/07/2012 | CN102766184A Protopanoxadiol peroxide derivatives as well as preparation method and application thereof |
11/07/2012 | CN102766183A Anti-HIV-1 fusion activity-modified nucleic acid structure |
11/07/2012 | CN102766180A Purification method for two active monomer compounds in saxifrage and application of product of the same |
11/07/2012 | CN102766165A Methods for synthesizing molybdopterin precursor z derivatives |
11/07/2012 | CN102766148A Cefamandole nafate compound and composite thereof |
11/07/2012 | CN102766145A Fluorinated aza imidazolone derivative, synthesis method and application thereof |
11/07/2012 | CN102766142A Lactam compounds useful as protein kinase inhibitors |
11/07/2012 | CN102766135A Dihydrofuran indenoane-imidazole salts compound and preparation method thereof |
11/07/2012 | CN102766134A Dabigatran etexilate derivative and preparation method and application thereof |
11/07/2012 | CN102766122A Derivatives of dihydroaurone, benzofuran and orange alkane, and uses thereof |
11/07/2012 | CN102766111A 3,4-diaryl-1,2,5-selenadiazole derivative and its application |
11/07/2012 | CN102766109A 2,3-diaryl thiazolidine-4-one/-thioketone compounds, oxides thereof and use thereof |
11/07/2012 | CN102766103A 2-sulfo-4-amino-1-naphthol derivative and preparation method and application thereof |
11/07/2012 | CN102766099A Compound with xanthine oxidase inhibitory activity as well as salt, preparation methods and application thereof |
11/07/2012 | CN102766098A Process and intermediates for preparing integrase inhibitors |
11/07/2012 | CN102766083A 2-amino-3-perfluoro acetoindole compound and its derivative, preparation method and application thereof |
11/07/2012 | CN102766080A Pyrrolidine derivative, its preparation method and application thereof |
11/07/2012 | CN102766079A Pyrrolidine derivative, its preparation method and application thereof |
11/07/2012 | CN102766068A Halogenated salicyloyl arylamine compounds as well as preparation method and application thereof |
11/07/2012 | CN102764440A Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
11/07/2012 | CN102764439A Association between 4-benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it |
11/07/2012 | CN102764437A Methoxsalen injection and preparation method thereof |
11/07/2012 | CN102764429A Composition used for increasing regulatory T cells in vivo and use thereof |
11/07/2012 | CN102764426A Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof |
11/07/2012 | CN102764417A Chinese materia medica frostbite cream |
11/07/2012 | CN102764408A Dealcoholic preparation |
11/07/2012 | CN102764398A Medicine for relieving cough, resolving sputum and relieving asthma and preparation method thereof |
11/07/2012 | CN102764365A Use of anemarrhena or active ingredient thereof in preparation of drug or product for prevention and treatment of electromagnetic radiation damage |
11/07/2012 | CN102764359A Traditional Chinese medicine for treating enteritis and dysentery |
11/07/2012 | CN102764342A Ointment for treating bedsore, diabetic wound and scald |
11/07/2012 | CN102764331A External medicine for treating nail ringworm and whitlow |
11/07/2012 | CN102764330A Medicine composition for treating cutaneous pruritus and preparation method thereof |
11/07/2012 | CN102764328A Externally-applied medicinal liquid for curing vitiligo |
11/07/2012 | CN102764320A Psychotria sp. extract, and preparation method and antineoplastic application thereof |
11/07/2012 | CN102764319A Traditional Chinese medicine vagina effervescent tablets for curing cervical erosion of women and preparation method thereof |
11/07/2012 | CN102764303A Preparation for safe and efficient arsenic-free pulp devitalizer and application thereof |
11/07/2012 | CN102764300A Externally used Chinese medicine preparation for curing viral dermatoses and preparation method |
11/07/2012 | CN102764291A Tincture medicine for treating tinea versicolor |
11/07/2012 | CN102764280A Bezoar and musk containing pharmaceutical composition and its application |
11/07/2012 | CN102764278A External use drug for treating hemorrhoids |
11/07/2012 | CN102764277A Suction therapy for repairing brain cells, containing cerebral hemorrhage and enhancing immune system |
11/07/2012 | CN102764271A Dual component oral care product |
11/07/2012 | CN102764267A Carbomer cervical gel |
11/07/2012 | CN102764266A Application of fucoidan sulfate in preparation of drug for preventing and treating chronic obstructive pulmonary disease (COPD) |
11/07/2012 | CN102764265A Application of rheum emodin-8-beta-D-glucoside in preparation of medicines and health-care products for treating synaptic dysfunctional diseases |
11/07/2012 | CN102764264A Celecoxib solid composition with high dissolution, preparation method and application |
11/07/2012 | CN102764263A Application of 5alpha-8alpha-ergosterol peroxide-6,22(E)-diene-3beta-alcohol to preparation of anti-tumor drug |
11/07/2012 | CN102764262A Application of oleanolic acid and retinoic acid pharmaceutical composition to medicament for treating insulin resistance and diabetes |
11/07/2012 | CN102764261A Oral composition controlling release of trimetazidine dihydrochloride and preparation method of oral composition |
11/07/2012 | CN102764260A Pharmaceutical composition of camptothecin derivative and preparation method thereof |
11/07/2012 | CN102764259A Application of sanguinarine compound in preparation of drug for preventing and treating caner and pharmaceutical composition |
11/07/2012 | CN102764258A Preparation method of candesartan cilexetil amlodipine compound tablet |
11/07/2012 | CN102764257A Flupirtine maleate sustained release tablet |
11/07/2012 | CN102764256A Ointment for treating acnes |
11/07/2012 | CN102764255A Hemodynamics improving agent |
11/07/2012 | CN102764254A Levetiracetam drug composition and preparation method thereof |
11/07/2012 | CN102764253A Application of benzopyran alkaloid |
11/07/2012 | CN102764252A Application of valnemulin hydrochloride |
11/07/2012 | CN102764251A Simple and effective method for externally treating internal diseases |
11/07/2012 | CN102764250A Composition composed of taurine and ginkgolide A and application thereof |
11/07/2012 | CN102764249A Use of geranylgeranylacetone for preventing and treating renal injuries caused by morphine |